Wordt geladen...

Subcutaneous abatacept for the treatment of rheumatoid arthritis

The efficacy, safety and tolerability of i.v. abatacept are well established in patients with active RA. A s.c. abatacept formulation is now available in some countries. Here, we review clinical data for s.c. abatacept. Six trials are presented (Phase II dose-finding study, ACQUIRE, ALLOW, ACCOMPANY...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteur: Schiff, Michael
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2013
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3651617/
https://ncbi.nlm.nih.gov/pubmed/23463804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/ket018
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!